Interaction of SARS-COV2 and influenza virus with particulate matter air pollution
Interaction of SARS-COV2 and influenza virus with particulate matter air pollution
批准号:
2721869
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Patients infected with influenza and SARS-CoV-2 are more than twice as likely to die as someone with SARS-CoV-2 alone (Stowe J, 2020) There is evidence of higher transmission rates and worsening of health outcomes when subjects are also exposed to high levels of ambient particulate matter (PM) pollution (Lu, 2020). As documented with the COVID-19 pandemic, evidence from Lombardy, Italy, suggested that higher ambient levels and daily fluctuations of pollution, increase the rate of COVID-19 infection (Setti L, 2020). SARS-CoV-2 has been detected indirectly on PM in pollution via RNA extraction and polymerase chain reaction (PCR) (Setti L et al, 2020). Viable SARS-CoV-2 virus (detected by PCR and positive culture) has been shown in the ultrafine fraction of PM with diameters of 250-500 nm (Lednicky JA, 2021), raising the possibility that these particles could act as a vector for SARS-CoV-2, but there is no direct visual evidence as to whether these particles form hybrids. If PM and the respiratory viruses interact in air, the resulting particle-hybrid could affect airborne spread, transmission and infectivity. On the other hand specific components of PM are redox active and there is very recent evidence that diesel PM can deactivate influenza viruses (Hsiao TC, 2021). This PhD will test the hypothesis that PM acts as a vector for SARS-CoV-2 and influenza viruses, increasing the potential for airborne spread of the virus, infectivity and for boosting cellular inflammatory response. In addition, it will establish whether influenza or SARS-COV-2 interact with specific components of PM and whether specific PM chemistries amplify or protect against cellular damage. The outcomes will provide guidance around which polluted microenvironments are potentially most unsafe for infection and could shed light on new therapeutic interventions.Task 1 will optimise infection and PM dosing of human epithelial cells. Task 2 will determine response of human nasal epithelial cells Human Nasal Airway Epithelial Cells (HNE) to SARS-CoV-2-infected and PM. Task 3 will assess whether SARS-CoV2 adheres to PM in the cellular environment. EPSRC areas: particle technology and biophysics
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
SUMO化介导泛素化修饰类型调控N蛋白水平及SARS-CoV-2复制的机制研究
-
批准号:JCZRQN202500077
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
SARS-CoV-2 VLP调控肿瘤微环境影响三阴性乳腺癌发生发展的机制
研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
基于Smad3调控铁死亡和炎症反应探讨SARS-CoV-2N蛋白诱发糖尿病基础上急性肾损伤的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:梁莉莹
-
依托单位:
SARS-TRNAU1AP调控小胶质细胞tRNA稳定性在生发基质-脑室出血后神经炎症的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:李鹏
-
依托单位:
靶向SARS-CoV-2 S1蛋白中药多糖活性化合物的筛选及构效关系研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2024
-
负责人:李美霞
-
依托单位:
cGAS-STING 通路在 SARS-CoV-2 感染致急性肺损
伤的机制研究
-
批准号:2024JJ2038
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:晏锡泉
-
依托单位:
SARS相关冠状病毒刺突蛋白不同功能区的协同作用及其机制研究
-
批准号:32300141
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:郭华
-
依托单位:
SARS-CoV-2 N蛋白激活SCAP-SREBP2/Notch1信号通路促进动脉粥样硬化进展及其机制研究
-
批准号:82360101
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:刘米华
-
依托单位:
SARS-CoV-2及其变异株B/T细胞表位的鉴定及表位疫苗的设计和免疫保护性研究
-
批准号:82302065
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:雷清
-
依托单位:
腺苷酸转位酶在SARS-CoV-2感染中的作用及分子机制研究
-
批准号:32302955
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:李乐天
-
依托单位: